The FDA Hasn’t Inspected This Drug Factory After 7 Recalls for the Same Flaw, 1 Potentially Deadly

Indian drugmaker Glenmark Pharmaceuticals issued a string of recalls for pills that didn’t dissolve properly.

The company got reports of three deaths of patients who took the recalled pills.

A lawsuit alleges the pills killed a 91-year-old woman in Maine .

The FDA 's anemic response underscores longstanding weaknesses in the way the agency oversees safety of generic medications made in foreign factories.

Four people died and others had to have their eyeballs removed after they used contaminated eyedrops made by a different Indian company.

The FDA had never inspected that factory before people got sick.

The House Committee on Energy and Commerce in June demanded that the head of the FDA turn over documents.

An Associated Press analysis found that about 2,000 pharmaceutical plants had not been inspected by the FDA in five years .

People familiar with FDA enforcement say inspectors are often frustrated because they have little say on which facilities they inspect.

The FDA doesn’t make it easy for people to know where a drug is made, let alone whether it was made by a factory with a concerning safety record.